In the study, scientists used a spray. Nasal vestibulitis is not usually an emergency. However, if a person with a weakened immune system develops a fever, they should go to the emergency room ...

Lauren is a freelance contributor to Newsweek’s personal finance team. She is passionate about educating people on how to transform their finances from a source of stress to a tool in creating a ...

Jennifer B Higgins has been appointed as the acting USCIS director. She has previously served as the USCIS deputy director and in other leadership positions. USCIS manages immigration benefits in ...

Major streamers, such as Netflix and Max, are producing must-watch television series on a regular basis. From “Stranger Things” to “House of the Dragon,” there’s no shortage of ...

Given that many of us use their phones for important daily tasks, we can't simply wait an hour or more for it to charge. Thankfully, most phones nowadays have some sort of fast charging support. Some ...

Explaining his decision to pursue a law degree, Rishi revealed that he didn't know if acting was "a viable option as a person of colour". "Growing up, I never really saw anyone who looked like me ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato ... therapies could provide unique and fast-acting antidepressant benefits.

On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...